Piper Sandler analysts reiterated a Overweight rating on AbbVie Inc. (NYSE:ABBV) on February 18, 2026.
AbbVie Inc. operates in the Healthcare sector. The stock currently trades at $228.72 with a market capitalization of $395.7B. The stock has gained 24.6% over the past 52 weeks.